JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 11 1777-1783
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Daisu, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Daisu, M.

The Diagnostic Value of 123I-IMP SPECT in Non-Hodgkin's Lymphoma of the Central Nervous System

Yasuhiko Akiyama, Kouzo Moritake, Toshiki Yamasaki, Yoriyoshi Kimura, Akira Kaneko, Yoshiaki Yamamoto, Takeshi Miyazaki and Mitsuhiro Daisu

Department of Neurosurgery, Shimane Medical University, Izumo, Japan

N-isopropyl-p-[123I]iodoamphetamine (IMP) SPECT is of low diagnostic value in patients with brain tumors, because brain tumors are visualized as uptake defects. Some reports have described non-Hodgkin's lymphoma of the central nervous system (CNS) as showing high uptake on delayed 123I-IMP SPECT images, suggesting its usefulness in diagnosing CNS lymphoma. In this study, we investigated the clinical value of 123I-IMP SPECT as a diagnostic tool for CNS lymphoma. Methods: Ninety-six patients with brain tumors, including 12 patients with CNS lymphoma, underwent 123I-IMP SPECT. Eleven patients had primary CNS lymphoma, and 1 had a parenchymal brain metastasis from a breast lymphoma. The total number of lesions was 18, 14 of which were in the cerebral parenchyma, 3 in the brain stem, and 1 in the ventricle. Early SPECT images were initiated 15–30 min after intravenous injection of 111 MBq 123I-IMP, and delayed images were collected 4 h later. SPECT images were visually analyzed with a color-grading scale. Tumor-to-normal activity ratio (T/N) and tumor-to-cerebellum activity ratio (T/C) were calculated for both early and delayed images for semiquantitative analysis. Results: By visual estimation, more than a 3- cm3 volume of CNS lymphoma was detected as an obvious focus of increased accumulation on delayed images. All other brain tumors tested appeared as decreased accumulation on delayed images. T/Ns and T/Cs on delayed images of CNS lymphomas, including tumors less than 3 cm3 in volume, were 1.48 ± 0.42 and 1.08 ± 0.16, respectively. These ratios in patients with glioma (0.30 ± 0.05 and 0.31 ± 0 07 respectively) or meningioma (0.34 ± 0.10 and 0.41 ± 0.17, respectively) showed a significant difference from those in patients with CNS lymphoma (P < 0.0005). Conclusion: 123I-IMP SPECT is a helpful tool for diagnosing CNS lymphoma.

Key Words: brain neoplasm • non-Hodgkin's lymphoma • SPECT • N-isopropyl-p-[123I]iodoamphetamine

Received Oct. 29, 1999; revision accepted Mar. 8, 2000.

For correspondence or reprints contact: Yasuhiko Akiyama, MD, PhD, 89-1 Enya-cho, Izumo Shimane 693-8501, Japan.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
C. Miyazaki, M. Mukai, Y. Kawaai, M. Takeda, N. Katoh, S. Nagano, K. Kubo, and M. Kohno
A Case of Intravascular Lymphoma with Increased Regional Cerebral Blood Flow in I-123 IMP Single-Photon Emission CT
AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 565 - 570.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.